Abstract
We assessed risk factors for and outcomes of linezolid-resistant vancomycin-resistant Enterococcus faecium (LRVREF) bacteremia over 7 years. Thirty-four LRVREF cases were matched to 68 linezolid-susceptible VREF controls. The odds of bacteremia with LRVREF increased by 7% for each additional day of prior linezolid exposure.
Keywords:
Enterococcus faecium; Linezolid-resistant enterococci; VRE.
Copyright © 2018 Elsevier Inc. All rights reserved.
MeSH terms
-
Adult
-
Aged
-
Anti-Bacterial Agents / pharmacology*
-
Anti-Bacterial Agents / therapeutic use
-
Drug Resistance, Multiple, Bacterial / drug effects*
-
Enterococcus faecium / drug effects*
-
Female
-
Gram-Positive Bacterial Infections / drug therapy
-
Gram-Positive Bacterial Infections / microbiology*
-
Humans
-
Linezolid / pharmacology*
-
Linezolid / therapeutic use
-
Male
-
Middle Aged
-
Retrospective Studies
-
Time Factors
-
Vancomycin-Resistant Enterococci / drug effects*
Substances
-
Anti-Bacterial Agents
-
Linezolid